BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22530758)

  • 21. Early Brain Injury or Vasospasm? An Overview of Common Mechanisms.
    Topkoru B; Egemen E; Solaroglu I; Zhang JH
    Curr Drug Targets; 2017; 18(12):1424-1429. PubMed ID: 27593685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subarachnoid Hemorrhage.
    Chou SH
    Continuum (Minneap Minn); 2021 Oct; 27(5):1201-1245. PubMed ID: 34618758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies.
    Osgood ML
    Curr Neurol Neurosci Rep; 2021 Jul; 21(9):50. PubMed ID: 34308493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aneurysmal subarachnoid hemorrhage: an overview for the practicing neurologist.
    Dupont SA; Wijdicks EF; Lanzino G; Rabinstein AA
    Semin Neurol; 2010 Nov; 30(5):545-54. PubMed ID: 21207347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic manipulation in the neuro-intensive care unit: cerebral perfusion pressure therapy in head injury and hemodynamic augmentation for cerebral vasospasm.
    Diringer MN; Axelrod Y
    Curr Opin Crit Care; 2007 Apr; 13(2):156-62. PubMed ID: 17327736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effect of hydrogen-rich saline on cerebral vasospasm after experimental subarachnoid hemorrhage in rats.
    Hong Y; Guo S; Chen S; Sun C; Zhang J; Sun X
    J Neurosci Res; 2012 Aug; 90(8):1670-80. PubMed ID: 22589232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage.
    Budohoski KP; Guilfoyle M; Helmy A; Huuskonen T; Czosnyka M; Kirollos R; Menon DK; Pickard JD; Kirkpatrick PJ
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1343-53. PubMed ID: 24847164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
    Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
    Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of recombinant streptokinase on the development of chronic cerebral vasospasm after subarachnoid hemorrhage in a swine model.
    Xu H; Chen X; Qin Z; Gu Y; Zhou P
    Acta Neurochir (Wien); 2011 Jun; 153(6):1333-8; discussion 1338. PubMed ID: 21311917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage.
    Daou BJ; Koduri S; Thompson BG; Chaudhary N; Pandey AS
    CNS Neurosci Ther; 2019 Oct; 25(10):1096-1112. PubMed ID: 31583833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage.
    Ducruet AF; Gigante PR; Hickman ZL; Zacharia BE; Arias EJ; Grobelny BT; Gorski JW; Mayer SA; Connolly ES
    J Cereb Blood Flow Metab; 2010 Apr; 30(4):676-88. PubMed ID: 20068580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Extracranial Consequences of Subarachnoid Hemorrhage.
    Hall A; O'Kane R
    World Neurosurg; 2018 Jan; 109():381-392. PubMed ID: 29051110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current and future treatment considerations in the management of aneurysmal subarachnoid hemorrhage.
    Rhoney DH; McAllen K; Liu-DeRyke X
    J Pharm Pract; 2010 Oct; 23(5):408-24. PubMed ID: 21507846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Origins of the Concept of Vasospasm.
    Macdonald RL
    Stroke; 2016 Jan; 47(1):e11-5. PubMed ID: 26337970
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of delayed cerebral ischemia after subarachnoid hemorrhage.
    Koenig MA
    Continuum (Minneap Minn); 2012 Jun; 18(3):579-97. PubMed ID: 22810250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia.
    Vergouwen MD; Vermeulen M; Coert BA; Stroes ES; Roos YB
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1761-70. PubMed ID: 18628782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide related pathophysiological changes following subarachnoid haemorrhage.
    Sabri M; Ai J; Macdonald RL
    Acta Neurochir Suppl; 2011; 110(Pt 1):105-9. PubMed ID: 21116924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are optimal cerebral perfusion pressure and cerebrovascular autoregulation related to long-term outcome in patients with aneurysmal subarachnoid hemorrhage?
    Rasulo FA; Girardini A; Lavinio A; De Peri E; Stefini R; Cenzato M; Nodari I; Latronico N
    J Neurosurg Anesthesiol; 2012 Jan; 24(1):3-8. PubMed ID: 21709587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.